BNTX

BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit

BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit

BioNTech posts wider-than-expected Q4 loss of $0.33/share as COVID vaccine revenue plunges 24% year-over-year; founders to exit for new mRNA…

BioNTech SE (BNTX) Reports Q4 Earnings

**BioNTech SE Reports Q4 2025 Results**

BioNTech SE (BNTX) Q2 2022 Earnings conference

BioNTech SE (NASDAQ: BNTX) Q2 2022 Earnings Conference

BioNTech SE (BNTX) Q1 2022

BioNTech SE (NASDAQ: BNTX) Q1 2022 Earnings Conference

BioNTech SE (BNTX) Q4 2021

BioNTech SE (NASDAQ: BNTX) Q4 2021 Earnings Conference

BioNTech SE (BNTX) Q3 2021 Earnings call

BioNTech SE (NASDAQ: BNTX) Q3 2021 Earnings Conference

BioNTech SE (BNTX) BioNTech Second Quarter 2021 Update Call

BioNTech SE (NASDAQ: BNTX) Q2 2021 Earnings Conference

BioNTech SE (BNTX) BioNTech to Report First Quarter 2021 Financial Results and Operational Update on May 10, 2021

BioNTech SE (NASDAQ: BNTX) Q1 2021 Earnings Conference

BioNTech SE (BNTX) BioNTech to Report Full Year Financial Results for 2020 and Provide Corporate Update on the Fourth Quarter on March 30, 2021

BioNTech SE (NASDAQ: BNTX) Q4 2020 Earnings Conference